SCHEMBL24482986

SCHEMBL24482986

COC(=O)c1c(Br)c2cc(Cl)ccc2n1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 4/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 2/20 0.43
PABPC1 P11940 1/20 0.43
EIF4H Q15056 1/20 0.43
NR4A2 P43354 2/20 0.43
GAA P10253 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
ABL1 P00519 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
EGFR P00533 1/20 0.41
MAPT P10636 2/20 0.40
PKM P14618 1/20 0.40
KMT2A Q03164 1/20 0.40
GABRA1 P14867 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24482981 0.89 MAPK8 (0.44) ALDH1A1KDM4EHPGDHSD17B10PABPC1
SCHEMBL8687098 0.85 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL24482987 0.84 KDM4E (0.49) ALDH1A1KDM4EHPGDHSD17B10PABPC1
SCHEMBL24482982 0.83 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDHSD17B10PABPC1
SCHEMBL24482985 0.80 CFTR (0.45) ALDH1A1KDM4EHPGDHSD17B10PABPC1
SCHEMBL24482887 0.79 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDHSD17B10PABPC1
SCHEMBL22022202 0.79 PLA2G2A (0.52) ALDH1A1KDM4EHPGDHSD17B10PABPC1
SCHEMBL21478268 0.77 PABPC1 (0.46) ALDH1A1KDM4EHPGDHSD17B10PABPC1
SCHEMBL6300552 0.76 ABCB11 (0.53) HSD17B10MAPTKMT2AMAPK8
SCHEMBL5234885 0.75 SMN1; SMN2 (0.52) ALDH1A1KDM4EHPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022111222-A1 AMIDE DERIVATIVE SERVING AS PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST, AND USE THEREOF 安润医药科技(苏州)有限公司 2022-06-02 WO disclosed